BioMedNewsBreaks — Astiva Health Achieves Remarkable 188% Membership Growth

Astiva, a leader in culturally responsive health care solutions, today announced a significant 188% growth in membership, increasing to 30,257 members as of January 2025 (up from 10,500 in January 2024). The milestone highlights Astiva’s position as a trusted provider of innovative health care tailored to diverse communities.

“Growing from 10,000 to over 30,000 members reflects the trust and confidence our communities have placed in Astiva Health,” said Dr. Tri T. Nguyen, co-founder and CEO. “This achievement validates our commitment to delivering culturally sensitive health care solutions that meet the unique needs of our members. We are excited to build on this momentum and continue enhancing our services to improve overall member well-being.”

To view the full press release, visit https://ibn.fm/Y0ZeY

About Astiva Health

Astiva is a leader in culturally responsive health care solutions, committed to bridging health care gaps for diverse and underserved populations. With a focus on delivering personalized care, Astiva empowers its members through innovative MAPD health plans, strategic partnerships and multilingual resources. Serving over 30,000 members across California, Astiva is redefining health care accessibility and equity through community integration and culturally tailored care. To learn more, visit www.AstivaHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to Astiva are available in the company’s newsroom at https://ibn.fm/Astiva

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN